CS
TRML

Credit Suisse’s Tourmaline Bio TRML Stock Holding History

Credit Suisse’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$429K Buy
+18,715
New +$660K ﹤0.01% 2701
2023
Q1 		– Hold
0
– -$1 – 3705
2022
Q4 		– Sell
-13
Closed -$209 – 3922
2022
Q3 		$0 Buy
13
+11
+550% +$401 ﹤0.01% 4294
2022
Q2 		$0 Buy
+2
New +$158 ﹤0.01% 4318

Other funds holding TRML

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

Credit Suisse's TRML Position: Q1 2024 in Review

Credit Suisse opened a new position in Tourmaline Bio (TRML) in Q1 2024: 18,715 shares worth $429K. The stake represents ﹤0.01% of the portfolio and ranks #2701 among its holdings. This is a return to the name: Credit Suisse previously reported a position in TRML as recently as Q3 2022.

Credit Suisse first reported a position in TRML in Q2 2022 and has held it in 3 quarters since. 96 funds tracked by Wall St. Rank hold TRML as of Q1 2024.

  • Credit Suisse held 18,715 shares of Tourmaline Bio worth $429K as of Q1 2024.
  • Tourmaline Bio was a new Credit Suisse position in Q1 2024.
  • Tourmaline Bio made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2701 holding.
  • Credit Suisse first reported a position in Tourmaline Bio in Q2 2022 and has held it in 3 quarters since.
  • 96 funds tracked by Wall St. Rank held Tourmaline Bio as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.